 |
| |
|
Our Mission
|
|
| |
We are an early stage biotechnology company dedicated to curing cancers by providing therapeutic vaccines to stimulate specific anti-tumor immune responses |
| |
We believe that, in many cases, cancer can be effectively managed by the person’s own immune system without the need for conventional chemotherapy.
A personalized cancer vaccine administered just weeks after tumor biopsy is designed to stimulate immune system to suppress cancer and to develop active long-term immunity against it in your whole body. TheraOne was founded to bring this life-extending therapy to the patients! |
 |
| |
|
Our Current Target
|
|
| |
Non-hodgkin’s Follicular B-cell Lymphoma (NHL)
We believe in changing the paradigm of lymphoma treatment by using personalized NHL vaccines as a front-line treatment delaying or negating the need for chemotherapy! |
 |
| |
|
Contact Information
|
|
| |
Thomas Theriault, Founder and CEO
1600 Adams Drive
Suite 122
Menlo Park, CA 94025
office: (650) 492 5322
fax: (650) 472 9095
email: ttheriault@theraone.com | |
|